Prostatic carcinoma: a Pakistani perspective

Area of Science:

• Oncology
• Urology
• Public Health

Background:

• Prostatic adenocarcinoma is highly prevalent in Pakistan, ranking as the third most common male malignancy.
• It is the leading cancer in males aged 70-80 years, accounting for 15-25% of all male neoplasms.
• A significant proportion of cancer cases in Pakistan, including prostate cancer, are diagnosed at advanced stages.

Purpose of the Study:

• To highlight the high incidence of prostatic adenocarcinoma in Pakistan.
• To underscore the advanced stage at diagnosis for this common cancer.
• To emphasize the limited availability of diagnostic and therapeutic modalities.

Main Methods:

• Analysis of data from radical prostatectomy specimens.
• Review of existing epidemiological data on male malignancies in Pakistan.
• Assessment of diagnostic and therapeutic options for prostate cancer.

Main Results:

• Prostate cancer is the third most common malignancy in Pakistani males (approx. 7%).
• It is the most common malignancy in males in their 7th and 8th decades (15% and 25%).
• Radical prostatectomy specimens frequently show advanced stages (pT3a/pT3b) with extra-prostatic extension and positive margins.

Conclusions:

• Prostatic adenocarcinoma represents a significant oncological burden in Pakistan.
• Late diagnosis is common, characterized by advanced pathological staging.
• There is a critical need for improved diagnostic and therapeutic strategies for prostate cancer in the region.